JP2010507650A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010507650A5 JP2010507650A5 JP2009534061A JP2009534061A JP2010507650A5 JP 2010507650 A5 JP2010507650 A5 JP 2010507650A5 JP 2009534061 A JP2009534061 A JP 2009534061A JP 2009534061 A JP2009534061 A JP 2009534061A JP 2010507650 A5 JP2010507650 A5 JP 2010507650A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- drug according
- inflammatory
- inflammatory bowel
- autoimmune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 208000037911 visceral disease Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 108010078233 Thymalfasin Proteins 0.000 claims 1
- 102400000800 Thymosin alpha-1 Human genes 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 claims 1
- 229960004231 thymalfasin Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000584A ITRM20060584A1 (it) | 2006-10-27 | 2006-10-27 | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni |
| PCT/IT2007/000677 WO2008050363A2 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010507650A JP2010507650A (ja) | 2010-03-11 |
| JP2010507650A5 true JP2010507650A5 (enExample) | 2010-11-11 |
Family
ID=39322489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009534061A Pending JP2010507650A (ja) | 2006-10-27 | 2007-09-27 | 自己免疫疾患の予防及び治療用の薬剤を調製するためのチモシンアルファ１の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100004174A1 (enExample) |
| EP (1) | EP2086569A2 (enExample) |
| JP (1) | JP2010507650A (enExample) |
| KR (1) | KR20090096688A (enExample) |
| CN (1) | CN101534853A (enExample) |
| AU (1) | AU2007310416A1 (enExample) |
| BR (1) | BRPI0718010A2 (enExample) |
| CA (1) | CA2666609A1 (enExample) |
| EA (1) | EA200900602A1 (enExample) |
| IL (1) | IL198291A0 (enExample) |
| IT (1) | ITRM20060584A1 (enExample) |
| MX (1) | MX2009004196A (enExample) |
| WO (1) | WO2008050363A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100248272A1 (en) * | 2009-03-31 | 2010-09-30 | Cornell University | Method for identifying Smk box riboswitch modulating compounds |
| WO2025078961A1 (en) * | 2023-10-13 | 2025-04-17 | Gufic Biosciences Limited | Composition and method for treatment of endometriosis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5852225A (ja) * | 1981-09-22 | 1983-03-28 | Mitsui Pharmaceut Inc | 脱髄疾患治療剤 |
| US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
| TW249754B (enExample) * | 1993-10-26 | 1995-06-21 | Alpha I Biomedicals Inc | |
| US5888980A (en) * | 1994-06-30 | 1999-03-30 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
| CA2270223A1 (en) * | 1996-10-28 | 1998-05-07 | Carson B. Burgstiner (Deceased) | Methods and compositions for dietary supplementation |
| CN1198950A (zh) * | 1998-04-24 | 1998-11-18 | 崔泊 | 一种结肠炎新药的制备 |
| CN1628796A (zh) * | 2004-08-20 | 2005-06-22 | 康合堂 | 一种治疗溃疡性结肠炎的药物 |
-
2006
- 2006-10-27 IT IT000584A patent/ITRM20060584A1/it unknown
-
2007
- 2007-09-27 JP JP2009534061A patent/JP2010507650A/ja active Pending
- 2007-09-27 BR BRPI0718010-1A patent/BRPI0718010A2/pt not_active IP Right Cessation
- 2007-09-27 CN CNA200780040140XA patent/CN101534853A/zh active Pending
- 2007-09-27 WO PCT/IT2007/000677 patent/WO2008050363A2/en not_active Ceased
- 2007-09-27 MX MX2009004196A patent/MX2009004196A/es not_active Application Discontinuation
- 2007-09-27 AU AU2007310416A patent/AU2007310416A1/en not_active Abandoned
- 2007-09-27 EA EA200900602A patent/EA200900602A1/ru unknown
- 2007-09-27 EP EP07827728A patent/EP2086569A2/en not_active Withdrawn
- 2007-09-27 CA CA002666609A patent/CA2666609A1/en not_active Abandoned
- 2007-09-27 KR KR1020097007708A patent/KR20090096688A/ko not_active Withdrawn
- 2007-09-27 US US12/446,670 patent/US20100004174A1/en not_active Abandoned
-
2009
- 2009-04-22 IL IL198291A patent/IL198291A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522242A5 (enExample) | ||
| EP2622105A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF INFLAMMABLE ENDURANCE DISEASES | |
| SI2294012T1 (sl) | Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni | |
| CL2007002866A1 (es) | Compuestos derivados de 6-sustituidos-2-(bencimidazolil) purina y purinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades autoinmunes, enfermedad inflamatoria, enfermedad mediada por m | |
| EP2043679A4 (en) | CYTOTOXIC T-LYMPHOCYTE INDUCTIVE IMMUNOGENES FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER | |
| EP2051760A4 (en) | ADMINISTRATION OF ANTI-THERAPY | |
| EP2201370A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE-2 DIABETES | |
| SI2104682T1 (sl) | Diagnostika in zdravljenje Alzheimerjeve bolezni in drugih nevrodementnih bolezni | |
| EP2069768A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE-2 DIABETES | |
| JP2009513660A5 (enExample) | ||
| IL210916A (en) | Clonidine and medicinal products containing it for the prevention or treatment of mucosal inflammation | |
| EP2753348A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER WITH AN INTERFERON ALPHA CONJUGATE | |
| JP2014526559A5 (enExample) | ||
| EP2342215A4 (en) | METHOD AND COMPOSITION FOR CHLAMYDIA ANTIGEN FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA INFECTION AND DETECTION | |
| EP2140882A4 (en) | MEDICINE FOR THE TREATMENT OF LUNG DISEASES | |
| JP2010001264A5 (enExample) | ||
| EP1889058A4 (en) | DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS | |
| EP2220208A4 (en) | USE OF HAPTOGLOBIN ENTYPIZATION FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES | |
| EP2231148A4 (en) | Pharmaceutical composition for the treatment and prevention of heart disease | |
| FR2918282B1 (fr) | Medicament pour le traitement de la maladie de parkinson | |
| JP2008517059A5 (enExample) | ||
| EP2217573A4 (en) | TREATMENT AND PREVENTION OF VIRUS INFECTIONS | |
| JP2010507650A5 (enExample) | ||
| EP2522356A4 (en) | BIOACTIVE FRACTION OF PETIVERIA ALLIACEA, PHARMACEUTICAL COMPOSITION THEREOF AND COMBINATION WITH IMMUNOSTIMULATORS FOR THE TREATMENT OF CANCER | |
| EP2231146A4 (en) | Pharmaceutical composition for the treatment and prevention of glaucoma |